Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

被引:822
作者
Li, K
Foy, E
Ferreon, JC
Nakamura, M
Ferreon, ACM
Ikeda, M
Ray, SC
Gale, M
Lemon, SM
机构
[1] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA
[4] Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA
[5] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
innate immunity; IFN; IFN regulatory factor 3; NF-kappa B; protease inhibitor;
D O I
10.1073/pnas.0408824102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Toll-like receptors (TLRs) bind pathogen-specific ligands early in infection, initiating signaling pathways that lead to expression of multiple protective cellular genes. Many viruses have evolved strategies that block the effector mechanisms induced through these signaling pathways, but viral interference with critical proximal receptor interactions has not been described. We show here that the NS3/4A serine protease of hepatitis C virus (HCV), a virus notorious for its ability to establish persistent intrahepatic infection, causes specific proteolysis of Toll-IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF or TICAM-1), an adaptor protein linking TLR3 to kinases responsible for activating IFN regulatory factor 3 (IRF-3) and NF-kappaB, transcription factors controlling a multiplicity of antiviral defenses. NS3/4A-mediated cleavage of TRIF reduces its abundance and inhibits polyl:C-activated signaling through the TLR3 pathway before its bifurcation to IRF-3 and NF-kappaB. This uniquely broad mechanism of immune evasion potentially limits expression of multiple host defense genes, thereby promoting persistent infections with this medically important virus.
引用
收藏
页码:2992 / 2997
页数:6
相关论文
共 41 条
  • [11] The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense
    Harte, MT
    Haga, IR
    Maloney, G
    Gray, P
    Reading, PC
    Bartlett, NW
    Smith, GL
    Bowie, A
    O'Neill, LAJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (03) : 343 - 351
  • [12] Triggering the interferon response: The role of IRF-3 transcription factor
    Hiscott, J
    Pitha, P
    Genin, P
    Nguyen, H
    Heylbroeck, C
    Mamane, Y
    Algarte, M
    Lin, RT
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (01) : 1 - 13
  • [13] LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins
    Hoebe, K
    Beutler, B
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2004, 10 (02): : 130 - 136
  • [14] Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
    Hoebe, K
    Du, X
    Georgel, P
    Janssen, E
    Tabeta, K
    Kim, SO
    Goode, J
    Lin, P
    Mann, N
    Mudd, S
    Crozat, K
    Sovath, S
    Han, J
    Beutler, B
    [J]. NATURE, 2003, 424 (6950) : 743 - 748
  • [15] Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection:: common and unique pathways
    Iwamura, T
    Yoneyama, M
    Yamaguchi, K
    Suhara, W
    Mori, W
    Shiota, K
    Okabe, Y
    Namiki, H
    Fujita, T
    [J]. GENES TO CELLS, 2001, 6 (04) : 375 - 388
  • [16] Toll-like receptor control of the adaptive immune responses
    Iwasaki, A
    Medzhitov, R
    [J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 987 - 995
  • [17] Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing INF-β
    Jiang, ZF
    Mak, TW
    Sen, G
    Li, XX
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) : 3533 - 3538
  • [18] Viruses and interferon: A fight for supremacy
    Katze, MG
    He, YP
    Gale, M
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) : 675 - 687
  • [19] SPECIFICITY OF THE HEPATITIS-C VIRUS NS3 SERINE-PROTEASE - EFFECTS OF SUBSTITUTIONS AT THE 3/4A, 4A/4B, 4B/5A, AND 5A/5B CLEAVAGE SITES ON POLYPROTEIN PROCESSING
    KOLYKHALOV, AA
    AGAPOV, EV
    RICE, CM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (11) : 7525 - 7533
  • [20] An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
    Lamarre, D
    Anderson, PC
    Bailey, M
    Beaulieu, P
    Bolger, G
    Bonneau, P
    Bös, M
    Cameron, DR
    Cartier, M
    Cordingley, MG
    Faucher, AM
    Goudreau, N
    Kawai, SH
    Kukolj, G
    Lagacé, L
    LaPlante, SR
    Narjes, H
    Poupart, MA
    Rancourt, J
    Sentjens, RE
    St George, R
    Simoneau, B
    Steinmann, G
    Thibeault, D
    Tsantrizos, YS
    Weldon, SM
    Yong, CL
    Llinàs-Brunet, M
    [J]. NATURE, 2003, 426 (6963) : 186 - 189